Artificial intelligence×Cell biology

The Frontier Brief for this collision is still being written. The evidence below already reflects the current model run.

Pre-company space. No named players have staked this collision yet — an emerging pairing where the field, not a firm, is the story so far.

38 researchers publish on both sides of this collision without the fields themselves having met. Every name below is counted from papers in the corpus — not inferred.

• Zhenan BaoUniversity of Washington
  4/1
• Yang ZhangZhejiang University of Technology
  4/1
• David A. AgardUniversity of Idaho
  1/3
• Khanh Huy BuiTeva Pharmaceuticals (United States)
  1/3
• Sjors H. W. ScheresNIHR Cambridge Biomedical Research Centre
  3/1
• Yan LiuPfizer (United States)
  3/1
• Zev J. GartnerWhitehead Institute for Biomedical Research
  1/2
• Zibo ChenCalifornia Institute of Technology
  1/2
• Jason A. BurdickImperial College London
  1/2
• George M. ChurchColumbia University Irving Medical Center
  2/1

• Stanford UniversityUS
  279/127
• Harvard UniversityUS
  144/217
• Massachusetts Institute of TechnologyUS
  193/89
• University of California, BerkeleyUS
  222/73
• ETH ZurichCH
  125/121
• University of CambridgeGB
  126/111

• Cryo-electron microscopy snapshots of the spliceosome: structural insights into a dynamic ribonucleoprotein machine2017 · 205 citations · DOI ↗
  3
• Structure of the human 26S proteasome at a resolution of 3.9 Å2016 · 199 citations · DOI ↗
  3
• Distinct conformational states of SARS-CoV-2 spike protein2020 · 1,377 citations · DOI ↗
  2
• Artificial Cells: Synthetic Compartments with Life-like Functionality and Adaptivity2017 · 686 citations · DOI ↗
  2

Counted from the corpus. Institution counts use best-effort affiliation (every author on a paper is paired with every institution on it), so read them as presence, not headcount.